Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

MeSH terms

• Aged
• Aminobutyrates* / therapeutic use
• Angiotensin Receptor Antagonists* / therapeutic use
• Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
• Biphenyl Compounds*
• Drug Combinations*
• Female
• Heart Failure* / drug therapy
• Heart Failure* / physiopathology
• Humans
• Male
• Stroke Volume* / physiology
• Tetrazoles* / therapeutic use
• Treatment Outcome
• Valsartan* / therapeutic use